Toripalimab,Oxaliplatin,Capecitabine,Tegafur,gimeracil,oteracil
Coherus,Junshi Biosciences,nordic group,otsuka
['toripalimab', 'gastric']
rand phii study ct3a-4a n+ gastric/gej cancer periop sox/xelox +/- toripalimab (pd-1 inh): periop chemo + io higher trg 0/1 (44% vs 20%) and higher pcr rate (24% vs 9%) than chemo alone #asco23 intestinal subtype seemed to benefit more w/addition of io to periop tx 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope